Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 41 Breast Neoplasms 40 Lung Neoplasms 25 Carcinoma, Non-Small-Cell Lung 20 Colorectal Neoplasms 19 Uterine Cervical Neoplasms 13 Prostatic Neoplasms 13 Head and Neck Neoplasms 11 Carcinoma, Hepatocellular 11 Pancreatic Neoplasms 10 Melanoma 10 Ovarian Neoplasms 9 Neoplastic Cells, Circulating 7 Myelodysplastic Syndromes 7 Glioma 7 Esophageal Neoplasms 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Sarcoma 6 Multiple Myeloma 6 Gastrointestinal Neoplasms 6 Carcinoma, Renal Cell 6 Triple Negative Breast Neoplasms 5 Neoplasm Metastasis 5 Leukemia, Myeloid, Acute 5 Disease 5 Colonic Neoplasms 5 Uveal Melanoma 4 Skin Neoplasms 4 Neoplasm, Residual 4

Interventions

Doxorubicin 6 Specimen Handling 5 Radiotherapy 3 Radiation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Biopsy 3 pembrolizumab 2 liposomal doxorubicin 2 eribulin 2 Ifosfamide 2 toripalimab 1 talimogene laherparepvec 1 rucaparib 1 ribociclib 1 regorafenib 1 peposertib 1 pazopanib 1 olaratumab 1 olaparib 1 lenvatinib 1 futibatinib 1 durvalumab 1 dinutuximab 1 cemiplimab 1 cediranib 1 cabozantinib 1 avelumab 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Blood Specimen Collection × 1 year × Clear all

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡